ARROWHEAD PHARMACEUTICALS, INC. Retained Earnings
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Retained Earnings of -$1.92 billion as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-04
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$1.92B.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$1.73B.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$1.60B.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$1.63B.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$1.92B 10-Q · filed 2026-08-04 | |
| 2026-03-31 | -$1.73B 10-Q · filed 2026-05-07 | |
| 2025-12-31 | -$1.60B 10-Q · filed 2026-02-05 | |
| 2025-09-30 | -$1.63B 10-Q · filed 2026-08-04 | |
| 2025-06-30 | -$1.60B 10-Q · filed 2025-08-07 | |
| 2025-03-31 | -$1.43B 10-Q · filed 2025-05-12 | |
| 2024-12-31 | -$1.80B 10-Q · filed 2025-02-10 | |
| 2024-09-30 | -$1.63B 10-K · filed 2025-11-25 | |
| 2024-06-30 | -$1.45B 10-Q · filed 2024-08-08 | |
| 2024-03-31 | -$1.28B 10-Q · filed 2024-05-09 | |
| 2023-12-31 | -$1.16B 10-Q · filed 2024-02-06 | |
| 2023-09-30 | -$1.03B 10-K · filed 2024-11-26 | |
| 2023-06-30 | -$916.35M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | -$813.40M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | -$862.08M 10-Q · filed 2023-02-06 | |
| 2022-09-30 | -$820.75M 10-K · filed 2023-11-29 | |
| 2022-06-30 | -$735.24M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | -$663.20M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | -$707.56M 10-Q · filed 2022-02-02 | |
| 2021-09-30 | -$644.69M 10-K · filed 2022-11-28 | |
| 2021-06-30 | -$581.32M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | -$551.39M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | -$524.58M 10-Q · filed 2021-02-04 | |
| 2020-09-30 | -$503.84M 10-K · filed 2021-11-22 | -$503.84M 10-K · filed 2020-11-23 |
| 2020-06-30 | -$455.41M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | -$441.80M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | -$421.96M 10-Q · filed 2020-02-05 | |
| 2019-09-30 | -$419.29M 10-K · filed 2020-11-23 | |
| 2019-06-30 | -$431.00M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | -$451.33M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | -$475.23M 10-Q · filed 2019-02-07 | |
| 2018-09-30 | -$487.27M 10-K · filed 2019-11-25 | |
| 2018-06-30 | -$476.50M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | -$460.90M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | -$446.01M 10-Q · filed 2018-02-09 | |
| 2017-09-30 | -$432.82M 10-K · filed 2018-12-11 | |
| 2017-06-30 | -$422.08M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | -$416.56M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | -$410.52M 10-Q · filed 2017-02-06 | |
| 2016-09-30 | -$398.44M 10-K · filed 2017-12-12 | |
| 2016-06-30 | -$376.21M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | -$356.79M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | -$335.98M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | -$316.71M 10-K · filed 2016-12-14 | |
| 2015-06-30 | -$291.97M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | -$276.03M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | -$247.35M 10-Q · filed 2015-02-09 | |
| 2014-09-30 | -$224.77M 10-K · filed 2015-12-14 | |
| 2014-06-30 | -$202.34M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | -$190.71M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | -$176.77M 10-Q · filed 2014-02-04 | |
| 2013-09-30 | -$166.14M 10-K · filed 2014-11-25 | |
| 2013-06-30 | -$152.45M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | -$146.37M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | -$139.61M 10-Q · filed 2013-02-13 | |
| 2012-09-30 | -$135.00M 10-K · filed 2013-12-18 | |
| 2012-06-30 | -$129.68M 10-Q · filed 2012-08-13 | |
| 2012-03-31 | -$121.69M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | -$116.36M 10-Q · filed 2012-02-09 | |
| 2011-09-30 | -$113.87M 10-K · filed 2012-12-28 | |
| 2011-06-30 | -$111.10M 10-Q · filed 2011-08-08 | |
| 2010-09-30 | -$110.74M 10-K · filed 2011-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |